ARTICLE | Clinical News
Takecab vonoprazan fumarate regulatory update
February 2, 2015 8:00 AM UTC
Takeda said Japan approved an NDA for Takecab vonoprazan fumarate to treat acid-related diseases, including gastric ulcer, duodenal ulcer and reflux esophagitis. It is also approved as an adjunct to H...